| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 3 buys and 22 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $14.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2017 | Baroldi Paolo | SVP &Chief Medical Officer | Sale+OE | 16,300 | $15.51 | $252,775.51 | -23.1% | |
| Jan 3, 2017 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 23,330 | $15.48 | $361,241.72 | -2.7% | |
| Jan 3, 2017 | Gulino Richard L. | SVP, General Counsel &Sec. | Sale+OE | 10,900 | $15.51 | $169,089.52 | -54.5% | |
| Jan 3, 2017 | Kelly James Patrick | SVP, CFO &Treasurer | Sale+OE | 10,895 | $15.51 | $169,013.05 | -13.5% | |
| Sep 23, 2016 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Sell | 1,120,461 | $16.56 | $18,559,970.78 | -10.6% | |
| Sep 19, 2016 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Sell | 547,886 | $15.66 | $8,582,620.53 | -3.2% | |
| Jan 4, 2016 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 21,353 | $8.96 | $191,322.88 | -2.5% | |
| Jan 4, 2016 | Kelly James Patrick | SVP, CFO, Sec &Treasurer | Sale+OE | 9,564 | $8.96 | $85,693.44 | -13.6% | |
| Jan 4, 2016 | Baroldi Paolo | SVP &Chief Medical Officer | Sale+OE | 12,380 | $8.96 | $110,924.80 | -23.3% | |
| Dec 16, 2015 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 11,170 | $8.97 | $100,155.81 | +0.2% |